{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:51:34Z","timestamp":1790423494849,"version":"4.1.0"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Netherlands Organization for Scientific Research"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","plefa.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.plefa.2016.06.002","type":"journal-article","created":{"date-parts":[[2016,6,19]],"date-time":"2016-06-19T01:27:26Z","timestamp":1466299646000},"page":"131-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Molecular mechanism of lipid-induced cardiac insulin resistance and contractile dysfunction"],"prefix":"10.1016","volume":"136","author":[{"given":"Yilin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietbert","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan F.C.","family":"Glatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost J.F.P.","family":"Luiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2016.06.002_bib1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/cvr\/cvn301","article-title":"Energy metabolism in heart failure and remodelling","volume":"81","author":"Ingwall","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.plefa.2016.06.002_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.plefa.2016.06.002_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cmet.2007.10.013","article-title":"Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance","volume":"7","author":"Koves","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.plefa.2016.06.002_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1152\/physrev.00003.2009","article-title":"Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease","volume":"90","author":"Glatz","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.plefa.2016.06.002_bib5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bbrc.2007.01.141","article-title":"AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36","volume":"355","author":"Habets","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.plefa.2016.06.002_bib6","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1172\/JCI26955","article-title":"CD36 may determine our desire for dietary fats","volume":"115","author":"Abumrad","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.plefa.2016.06.002_bib7","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s00018-011-0690-x","article-title":"Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytes","volume":"68","author":"Steinbusch","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.plefa.2016.06.002_bib8","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.2337\/diabetes.54.6.1692","article-title":"Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects","volume":"54","author":"Karlsson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2016.06.002_bib9","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1016\/S0021-9258(17)34693-8","article-title":"Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA","volume":"253","author":"McGarry","year":"1978","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2016.06.002_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1997.00001.x","article-title":"The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis","volume":"244","author":"McGarry","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.plefa.2016.06.002_bib11","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1152\/ajpgi.00554.2006","article-title":"Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue","volume":"293","author":"Jaworski","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.plefa.2016.06.002_bib12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/cvr\/cvn093","article-title":"Insulin signalling in the heart","volume":"79","author":"Bertrand","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.plefa.2016.06.002_bib13","doi-asserted-by":"crossref","first-page":"32841","DOI":"10.1074\/jbc.M513087200","article-title":"Akt2 regulates cardiac metabolism and cardiomyocyte survival","volume":"281","author":"DeBosch","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2016.06.002_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/BJ20070649","article-title":"Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICAR","volume":"407","author":"Geraghty","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.plefa.2016.06.002_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cmet.2010.12.005","article-title":"Mice with AS160\/TBC1D4-Thr649Ala knockin mutation are glucose intolerant with reduced insulin sensitivity and altered GLUT4 trafficking","volume":"13","author":"Chen","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.plefa.2016.06.002_bib16","doi-asserted-by":"crossref","first-page":"25308","DOI":"10.1074\/jbc.274.36.25308","article-title":"Insulin activates protein kinases C-zeta and C-lambda by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes","volume":"274","author":"Standaert","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2016.06.002_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fphys.2012.00361","article-title":"Involvement of atypical protein kinase C in the regulation of cardiac glucose and long-chain fatty acid uptake","volume":"3","author":"Habets","year":"2012","journal-title":"Front Physiol."},{"key":"10.1016\/j.plefa.2016.06.002_bib18","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1007\/s00125-015-3691-8","article-title":"Extremely rapid increase in fatty acid transport and intramyocellular lipid accumulation but markedly delayed insulin resistance after high fat feeding in rats","volume":"58","author":"Bonen","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.plefa.2016.06.002_bib19","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00125-007-0735-8","article-title":"Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification","volume":"50","author":"Ouwens","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.plefa.2016.06.002_bib20","doi-asserted-by":"crossref","first-page":"50230","DOI":"10.1074\/jbc.M200958200","article-title":"Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle","volume":"277","author":"Yu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2016.06.002_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","article-title":"Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance","volume":"5","author":"Holland","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.plefa.2016.06.002_bib22","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0006-291X(88)80381-4","article-title":"Diacylglycerol activation of protein kinase C is modulated by long-chain acyl-CoA","volume":"152","author":"Bronfman","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.plefa.2016.06.002_bib23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1096\/fasebj.9.7.7737456","article-title":"Protein kinase C and lipid signaling for sustained cellular responses","volume":"9","author":"Nishizuka","year":"1995","journal-title":"FASEB J."},{"key":"10.1016\/j.plefa.2016.06.002_bib24","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0960-9822(95)00191-6","article-title":"Protein kinase C. Seeing two domains","volume":"5","author":"Newton","year":"1995","journal-title":"Curr. Biol."},{"key":"10.1016\/j.plefa.2016.06.002_bib25","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1074\/jbc.C600268200","article-title":"A single residue in the C1 domain sensitizes novel protein kinase C isoforms to cellular diacylglycerol production","volume":"282","author":"Dries","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2016.06.002_bib26","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2337\/diabetes.49.8.1353","article-title":"Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity","volume":"49","author":"Itani","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2016.06.002_bib27","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.plefa.2016.06.002_bib28","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1074\/jbc.M007231200","article-title":"Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin","volume":"276","author":"Ravichandran","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2016.06.002_bib29","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/01.HYP.0000163475.04421.e4","article-title":"Mechanisms of insulin resistance in humans and possible links with inflammation","volume":"45","author":"Savage","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.plefa.2016.06.002_bib30","doi-asserted-by":"crossref","first-page":"9597","DOI":"10.1073\/pnas.1409229111","article-title":"Role of diacylglycerol activation of PKCtheta in lipid-induced muscle insulin resistance in humans","volume":"111","author":"Szendroedi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.plefa.2016.06.002_bib31","doi-asserted-by":"crossref","first-page":"e26947","DOI":"10.1371\/journal.pone.0026947","article-title":"Palmitate-activated macrophages confer insulin resistance to muscle cells by a mechanism involving protein kinase C theta and epsilon","volume":"6","author":"Kewalramani","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.plefa.2016.06.002_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/BJ20120060","article-title":"CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes","volume":"448","author":"Angin","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.plefa.2016.06.002_bib33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nm1383","article-title":"CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK","volume":"12","author":"Watt","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.plefa.2016.06.002_bib34","doi-asserted-by":"crossref","first-page":"e37703","DOI":"10.1371\/journal.pone.0037703","article-title":"Inhibition of serine palmitoyl transferase I reduces cardiac ceramide levels and increases glycolysis rates following diet-induced insulin resistance","volume":"7","author":"Ussher","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.plefa.2016.06.002_bib35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1475-2840-12-172","article-title":"Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes","volume":"12","author":"Ramirez","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.plefa.2016.06.002_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s001250051596","article-title":"Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells","volume":"44","author":"Hajduch","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.plefa.2016.06.002_bib37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/bj3540359","article-title":"Ceramide dissociates 3'-phosphoinositide production from pleckstrin homology domain translocation","volume":"354","author":"Stratford","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.plefa.2016.06.002_bib38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/er.2007-0025","article-title":"Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism","volume":"29","author":"Holland","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.plefa.2016.06.002_bib39","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1210\/en.2010-0250","article-title":"Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors","volume":"151","author":"Frangioudakis","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.plefa.2016.06.002_bib40","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.2337\/db12-0029","article-title":"Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high-fat diet-fed mice","volume":"61","author":"Bruce","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2016.06.002_bib41","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1172\/JCI10947","article-title":"A novel mouse model of lipotoxic cardiomyopathy","volume":"107","author":"Chiu","year":"2001","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.plefa.2016.06.002_bib42","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1073\/pnas.0336724100","article-title":"A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content","volume":"100","author":"Finck","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.plefa.2016.06.002_bib43","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1172\/JCI30335","article-title":"Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice","volume":"117","author":"Son","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.plefa.2016.06.002_bib44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/01.RES.0000154079.20681.B9","article-title":"Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy","volume":"96","author":"Chiu","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.plefa.2016.06.002_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2337\/diabetes.53.1.25","article-title":"Ceramide content is increased in skeletal muscle from obese insulin-resistant humans","volume":"53","author":"Adams","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2016.06.002_bib46","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/CIRCULATIONAHA.111.060889","article-title":"Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure","volume":"125","author":"Chokshi","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.plefa.2016.06.002_bib47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0092-8674(00)81359-8","article-title":"Adipogenesis and obesity: rounding out the big picture","volume":"87","author":"Spiegelman","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.plefa.2016.06.002_bib48","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/2231-4040.90879","article-title":"The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases","volume":"2","author":"Tyagi","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.plefa.2016.06.002_bib49","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.RES.0000060700.55247.7C","article-title":"Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta\/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism","volume":"92","author":"Gilde","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.plefa.2016.06.002_bib50","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3945\/an.111.001602","article-title":"Mechanisms of gene regulation by fatty acids","volume":"3","author":"Georgiadi","year":"2012","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.plefa.2016.06.002_bib51","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nm1116","article-title":"Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy","volume":"10","author":"Cheng","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.plefa.2016.06.002_bib52","first-page":"99","article-title":"Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver","volume":"60","author":"Wierzbicki","year":"2009","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.plefa.2016.06.002_bib53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI0214080","article-title":"The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus","volume":"109","author":"Finck","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.plefa.2016.06.002_bib54","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.2337\/diabetes.54.9.2514","article-title":"Cardiac-specific overexpression of peroxisome proliferator-activated receptor-alpha causes insulin resistance in heart and liver","volume":"54","author":"Park","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2016.06.002_bib55","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.RES.0000264104.25265.b6","article-title":"CD36 deficiency rescues lipotoxic cardiomyopathy","volume":"100","author":"Yang","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.plefa.2016.06.002_bib56","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1172\/JCI3949","article-title":"A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice","volume":"102","author":"Djouadi","year":"1998","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.plefa.2016.06.002_bib57","doi-asserted-by":"crossref","first-page":"27307","DOI":"10.1074\/jbc.272.43.27307","article-title":"Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice","volume":"272","author":"Peters","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2016.06.002_bib58","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2337\/diabetes.50.12.2809","article-title":"PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance","volume":"50","author":"Guerre-Millo","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2016.06.002_bib59","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.diabres.2013.01.008","article-title":"Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy","volume":"100","author":"Lee","year":"2013","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.plefa.2016.06.002_bib60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1139\/y04-139","article-title":"Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice","volume":"83","author":"Aasum","year":"2005","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.plefa.2016.06.002_bib61","first-page":"3930","article-title":"Nuclear receptors PPARbeta\/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart","volume":"117","author":"Burkart","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.plefa.2016.06.002_bib62","doi-asserted-by":"crossref","first-page":"835985","DOI":"10.1155\/2015\/835985","article-title":"PPARs: protectors or opponents of myocardial function?","volume":"2015","author":"Pol","year":"2015","journal-title":"PPAR Res."},{"key":"10.1016\/j.plefa.2016.06.002_bib63","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2337\/diabetes.53.7.1655","article-title":"Enhanced sarcolemmal FAT\/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats","volume":"53","author":"Coort","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2016.06.002_bib64","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.108.792101","article-title":"Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart","volume":"119","author":"Boudina","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.plefa.2016.06.002_bib65","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.2174\/1381612811319270003","article-title":"Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies","volume":"19","author":"Ilkun","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.plefa.2016.06.002_bib66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/CS20070166","article-title":"Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome","volume":"114","author":"Bugger","year":"2008","journal-title":"Clin. Sci. Lond."},{"key":"10.1016\/j.plefa.2016.06.002_bib67","doi-asserted-by":"crossref","first-page":"476279","DOI":"10.1155\/2010\/476279","article-title":"Pathogenesis of insulin resistance in skeletal muscle","volume":"2010","author":"Abdul-Ghani","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.plefa.2016.06.002_bib68","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/jpi.12157","article-title":"Melatonin prevents mitochondrial dysfunction and insulin resistance in rat skeletal muscle","volume":"57","author":"Teodoro","year":"2014","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.plefa.2016.06.002_bib69","doi-asserted-by":"crossref","first-page":"H153","DOI":"10.1152\/ajpheart.01142.2008","article-title":"Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH","volume":"297","author":"Serpillon","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.plefa.2016.06.002_bib70","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00125-006-0229-0","article-title":"Cardiac contractile dysfunction in Lep\/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch","volume":"49","author":"Li","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.plefa.2016.06.002_bib71","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1463-1326.2011.01369.x","article-title":"Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction","volume":"13","author":"Roe","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.plefa.2016.06.002_bib72","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.bbamcr.2011.01.014","article-title":"Mitochondrial dysfunction in diabetic cardiomyopathy","volume":"1813","author":"Duncan","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plefa.2016.06.002_bib73","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/bmj.2.5053.1071","article-title":"Aspirin and diabetes mellitus","volume":"2","author":"Reid","year":"1957","journal-title":"Br. Med. J."},{"key":"10.1016\/j.plefa.2016.06.002_bib74","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.2337\/db08-1361","article-title":"Nutrient stress activates inflammation and reduces glucose metabolism by suppressing AMP-activated protein kinase in the heart","volume":"58","author":"Ko","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2016.06.002_bib75","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.yjmcc.2016.02.014","article-title":"CARD9 knockout ameliorates myocardial dysfunction associated with high fat diet-induced obesity","volume":"92","author":"Cao","year":"2016","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.plefa.2016.06.002_bib76","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jc.2013-3092","article-title":"Toll-like receptor status in obesity and metabolic syndrome: a translational perspective","volume":"99","author":"Jialal","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.plefa.2016.06.002_bib77","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1210\/er.2014-1100","article-title":"TLR4 at the crossroads of nutrients, Gut Microbiota, and metabolic inflammation","volume":"36","author":"Velloso","year":"2015","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.plefa.2016.06.002_bib78","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/212563","article-title":"TLR4 and insulin resistance","volume":"2010","author":"Kim","year":"2010","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.plefa.2016.06.002_bib79","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaci.2013.06.022","article-title":"Innate sensors of pathogen and stress: linking inflammation to obesity","volume":"132","author":"Jin","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.plefa.2016.06.002_bib80","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.2337\/diabetes.54.10.2939","article-title":"Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation","volume":"54","author":"Plomgaard","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2016.06.002_bib81","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1161\/CIRCULATIONAHA.111.090134","article-title":"Endothelial nuclear factor kappaB in obesity and aging: is endothelial nuclear factor kappaB a master regulator of inflammation and insulin resistance?","volume":"125","author":"Kim","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.plefa.2016.06.002_bib82","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI43378","article-title":"Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice","volume":"121","author":"Holland","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.plefa.2016.06.002_bib83","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cmet.2012.04.001","article-title":"Inflammation and lipid signaling in the etiology of insulin resistance","volume":"15","author":"Glass","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.plefa.2016.06.002_bib84","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4239\/wjd.v6.i7.943","article-title":"Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathy","volume":"6","author":"Waddingham","year":"2015","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.plefa.2016.06.002_bib85","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2337\/diabetes.50.5.1186","article-title":"Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance","volume":"50","author":"Dutta","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2016.06.002_bib86","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0168-8227(01)00323-0","article-title":"Prediabetic insulin resistance is not permissive to the development of cardiac resistance to insulin-like growth factor I in ventricular myocytes","volume":"55","author":"Hintz","year":"2002","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.plefa.2016.06.002_bib87","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.ijo.0802389","article-title":"Insulin resistance induces hyperleptinemia, cardiac contractile dysfunction but not cardiac leptin resistance in ventricular myocytes","volume":"27","author":"Hintz","year":"2003","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.plefa.2016.06.002_bib88","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2337\/diacare.13.11.1169","article-title":"Diabetic cardiomyopathy","volume":"13","author":"Fein","year":"1990","journal-title":"Diabetes Care"},{"key":"10.1016\/j.plefa.2016.06.002_bib89","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199108293250906","article-title":"Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction","volume":"325","author":"Morgan","year":"1991","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.plefa.2016.06.002_bib90","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0008-6363(97)00006-0","article-title":"Cytosolic Ca2+ concentration decreases in diabetic rat myocytes","volume":"34","author":"Hayashi","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.plefa.2016.06.002_bib91","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.yjmcc.2005.03.014","article-title":"Impaired SERCA function contributes to cardiomyocyte dysfunction in insulin resistant rats","volume":"39","author":"Wold","year":"2005","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.plefa.2016.06.002_bib92","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/01.RES.49.6.1243","article-title":"The effect of streptozotocin-induced diabetes in rats on cardiac contractile proteins","volume":"49","author":"Malhotra","year":"1981","journal-title":"Circ. Res."},{"key":"10.1016\/j.plefa.2016.06.002_bib93","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1536\/ihj.29.455","article-title":"Myocardial mechanical and myosin isoenzyme alterations in streptozotocin-diabetic rats","volume":"29","author":"Takeda","year":"1988","journal-title":"Jpn. Heart J."},{"key":"10.1016\/j.plefa.2016.06.002_bib94","doi-asserted-by":"crossref","first-page":"H408","DOI":"10.1152\/ajpheart.00049.2004","article-title":"Depressed cardiac tension cost in experimental diabetes is due to altered myosin heavy chain isoform expression","volume":"287","author":"Rundell","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.plefa.2016.06.002_bib95","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/HYPERTENSIONAHA.110.160655","article-title":"A murine model of isolated cardiac steatosis leads to cardiomyopathy","volume":"57","author":"Glenn","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.plefa.2016.06.002_bib96","doi-asserted-by":"crossref","first-page":"36312","DOI":"10.1074\/jbc.M109.049817","article-title":"DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity","volume":"284","author":"Liu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2016.06.002_bib97","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1476-5381.2011.01490.x","article-title":"Cardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPARalpha agonist","volume":"165","author":"Wolkart","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.plefa.2016.06.002_bib98","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/en.2010-0661","article-title":"Adipose triglyceride lipase-null mice are resistant to high-fat diet-induced insulin resistance despite reduced energy expenditure and ectopic lipid accumulation","volume":"152","author":"Hoy","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.plefa.2016.06.002_bib99","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/cvr\/cvt124","article-title":"Early structural and metabolic cardiac remodelling in response to inducible adipose triglyceride lipase ablation","volume":"99","author":"Kienesberger","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.plefa.2016.06.002_bib100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ijo.2013.103","article-title":"Cardiac-specific adipose triglyceride lipase overexpression protects from cardiac steatosis and dilated cardiomyopathy following diet-induced obesity","volume":"38","author":"Pulinilkunnil","year":"2014","journal-title":"Int. J. Obes. Lond."},{"key":"10.1016\/j.plefa.2016.06.002_bib101","doi-asserted-by":"crossref","first-page":"e61369","DOI":"10.1371\/journal.pone.0061369","article-title":"Palmitate diet-induced loss of cardiac caveolin-3: a novel mechanism for lipid-induced contractile dysfunction","volume":"8","author":"Knowles","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.plefa.2016.06.002_bib102","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrm2122","article-title":"The multiple faces of caveolae","volume":"8","author":"Parton","year":"2007","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.plefa.2016.06.002_bib103","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1083\/jcb.136.1.137","article-title":"Caveolin-3 associates with developing T-tubules during muscle differentiation","volume":"136","author":"Parton","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.plefa.2016.06.002_bib104","doi-asserted-by":"crossref","first-page":"21425","DOI":"10.1074\/jbc.M100828200","article-title":"Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities","volume":"276","author":"Galbiati","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2016.06.002_bib105","doi-asserted-by":"crossref","first-page":"38988","DOI":"10.1074\/jbc.M205511200","article-title":"Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42\/44 MAPK cascade","volume":"277","author":"Woodman","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2016.06.002_bib106","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/S0002-9440(10)61168-6","article-title":"Caveolin-1\/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype","volume":"160","author":"Park","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.plefa.2016.06.002_bib107","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbrc.2003.11.101","article-title":"Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy","volume":"313","author":"Hayashi","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.plefa.2016.06.002_bib108","doi-asserted-by":"crossref","first-page":"12670","DOI":"10.1073\/pnas.0402053101","article-title":"Insulin resistance in skeletal muscles of caveolin-3-null mice","volume":"101","author":"Oshikawa","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.plefa.2016.06.002_bib109","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/9780470985571.ch4","article-title":"Lipid-induced metabolic dysfunction in skeletal muscle","volume":"286","author":"Muoio","year":"2007","journal-title":"Novartis Found. Symp."},{"key":"10.1016\/j.plefa.2016.06.002_bib110","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/01.CIR.100.22.2248","article-title":"Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children","volume":"100","author":"Bonnet","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.plefa.2016.06.002_bib111","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1006\/jmcc.1997.0409","article-title":"Modulation of cardiac gap junctions: the mode of action of arachidonic acid","volume":"29","author":"Schmilinsky-Fluri","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.plefa.2016.06.002_bib112","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1096\/fj.00-0590","article-title":"Diseases of liporegulation: new perspective on obesity and related disorders","volume":"15","author":"Unger","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.plefa.2016.06.002_bib113","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11897-013-0133-0","article-title":"Cardiac lipotoxicity: molecular pathways and therapeutic implications","volume":"10","author":"Drosatos","year":"2013","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.plefa.2016.06.002_bib114","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.hfc.2012.06.003","article-title":"Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure","volume":"8","author":"Park","year":"2012","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.plefa.2016.06.002_bib115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00125-011-2367-2","article-title":"Subcellular lipid droplet distribution in red and white muscles in the obese Zucker rat","volume":"55","author":"Lally","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.plefa.2016.06.002_bib116","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of reactive oxygen species and NF-kappaB signaling","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.plefa.2016.06.002_bib117","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11892-008-0042-x","article-title":"The complexities of diabetic cardiomyopathy: lessons from patients and animal models","volume":"8","author":"Harmancey","year":"2008","journal-title":"Curr. Diabetes Rep."}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327816300825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327816300825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T23:07:53Z","timestamp":1656716873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327816300825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":117,"alternative-id":["S0952327816300825"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2016.06.002","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanism of lipid-induced cardiac insulin resistance and contractile dysfunction","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2016.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}